{
    "xml": "<topic id=\"PHP2950\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/phenobarbital\" basename=\"phenobarbital\" title=\"PHENOBARBITAL\">\n<title>PHENOBARBITAL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_437\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/phenobarbital\">Phenobarbital</xref>\n</p>\n<data name=\"vtmid\">51073002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_700688723\" title=\"Barbiturates\">Barbiturates</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n<p outputclass=\"synonyms\">Phenobarbitone</p>\r\n</body>\n<topic id=\"PHP47335\" outputclass=\"indicationsAndDose\" rev=\"1.37\" parent=\"/drugs/phenobarbital\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">All forms of epilepsy except typical absence seizures</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years</p>\n<p>Initially 1&#8211;1.5&#8239;mg/kg twice daily, then increased in steps of 2&#8239;mg/kg daily as required; maintenance 2.5&#8211;4&#8239;mg/kg 1&#8211;2 times a day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>60&#8211;180&#8239;mg once daily, dose to be taken at night.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>60&#8211;180&#8239;mg once daily, dose to be taken at night.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Status epilepticus</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8239;mg/kg (max. per dose 1&#8239;g), dose to be administered at a rate not more than 100&#8239;mg/minute, injection to be diluted 1 in 10 with water for injections.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup neonate\">\n<p>Neonate</p>\n<p>Initially 20&#8239;mg/kg, dose to be administered at a rate no faster than 1&#8239;mg/kg/minute, then 2.5&#8211;5&#8239;mg/kg 1&#8211;2 times a day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years</p>\n<p>Initially 20&#8239;mg/kg, dose to be administered at a rate no faster than 1&#8239;mg/kg/minute, then 2.5&#8211;5&#8239;mg/kg 1&#8211;2 times a day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 20&#8239;mg/kg (max. per dose 1&#8239;g), dose to be administered at a rate no faster than 1&#8239;mg/kg/minute, then 300&#8239;mg twice daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>For therapeutic purposes phenobarbital and phenobarbital sodium may be considered equivalent in effect.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47392\" outputclass=\"cautions\" rev=\"1.31\" parent=\"/drugs/phenobarbital\">\n<title>Cautions</title>\n<body>\r\n<section outputclass=\"cautions\">\r\n<p>\r\n<ph outputclass=\"caution\">Avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"caution\">children</ph>; <ph outputclass=\"caution\">debilitated</ph>; <ph outputclass=\"caution\">elderly</ph> (in adults); <ph outputclass=\"caution\">history of alcohol abuse</ph>; <ph outputclass=\"caution\">history of drug abuse</ph>; <ph outputclass=\"caution\">respiratory depression (avoid if severe)</ph>\r\n</p>\r\n </section>\r\n<section outputclass=\"importantAdvice\">\r\n<title>Cautions, further information</title>\r\n<sectiondiv>\r\n<p>Consider vitamin D supplementation in patients who are immobilised for long periods or who have inadequate sun exposure or dietary intake of calcium.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP47332\" outputclass=\"interactions\" rev=\"1.12\" parent=\"/drugs/phenobarbital\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (phenobarbital).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47288\" outputclass=\"sideEffects\" rev=\"1.25\" parent=\"/drugs/phenobarbital\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Agranulocytosis</ph>; <ph outputclass=\"sideEffect\">allergic skin reactions</ph>; <ph outputclass=\"sideEffect\">ataxia</ph>; <ph outputclass=\"sideEffect\">behavioural disturbances</ph>; <ph outputclass=\"sideEffect\">cholestasis</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">hallucinations</ph>; <ph outputclass=\"sideEffect\">hepatitis</ph>; <ph outputclass=\"sideEffect\">hyperactivity particularly in the elderly and in children</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">impaired cognition</ph>; <ph outputclass=\"sideEffect\">impaired memory</ph>; <ph outputclass=\"sideEffect\">irritability</ph>; <ph outputclass=\"sideEffect\">lethargy</ph>; <ph outputclass=\"sideEffect\">megaloblastic anaemia (may be treated with folic acid)</ph>; <ph outputclass=\"sideEffect\">nystagmus</ph>; <ph outputclass=\"sideEffect\">osteomalacia</ph>; <ph outputclass=\"sideEffect\">paradoxical excitement</ph> (in adults); <ph outputclass=\"sideEffect\">respiratory depression</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Antiepileptic Hypersensitivity Syndrome</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">suicidal ideation</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hyperkinesia</ph> (in children)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsOverdosageInformation\">\n<title>Overdose</title>\n<sectiondiv>\n<p outputclass=\"title\">Emergency treatment of poisoning: active elimination techniques</p>\n<p>Repeated doses of activated charcoal by mouth <i>enhance</i> the elimination of some drugs after they have been absorbed; repeated doses are given after overdosage with phenobarbital.</p>\n<p>The usual dose of activated charcoal in adults and children over 12 years of age is 50&#8239;g initially then 50&#8239;g every 4 hours. Vomiting should be treated (e.g. with an antiemetic drug) since it may reduce the efficacy of charcoal treatment. In cases of intolerance, the dose may be reduced and the frequency increased (e.g. 25&#8239;g every 2 hours or 12.5&#8239;g every hour) but this may compromise efficacy.</p>\n<p>In children under 12 years of age, activated charcoal is given in a dose of 1&#8239;g/kg (max. 50&#8239;g) every 4 hours; the dose may be reduced and the frequency increased if not tolerated.</p>\n<p>Other techniques intended to enhance the elimination of poisons after absorption are only practicable in hospital and are only suitable for a small number of severely poisoned patients. Moreover, they only apply to a limited number of poisons, for example, haemodialysis for phenobarbital.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47415\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.19\" parent=\"/drugs/phenobarbital\">\n<title>Allergy and cross-sensitivity</title>\n<body>\r\n\r\n<section outputclass=\"allergyAndCrossSensitivityCrossSensitivity\">\r\n<sectiondiv>\r\n<p>Antiepileptic hypersensitivity syndrome associated with phenobarbital. See under <xref format=\"dita\" href=\"#PHP78230\" type=\"bookmark\" namespace=\"/treatment-summaries/epilepsy\">Epilepsy</xref> for more information.</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP47403\" outputclass=\"breastFeeding\" parent=\"/drugs/phenobarbital\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid if possible; drowsiness may occur.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47351\" outputclass=\"hepaticImpairment\" parent=\"/drugs/phenobarbital\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>May precipitate coma.</p>\n<p>Avoid in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47299\" outputclass=\"renalImpairment\" parent=\"/drugs/phenobarbital\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47242\" outputclass=\"monitoringRequirements\" parent=\"/drugs/phenobarbital\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"therapeuticDrugMonitoring\">\n<sectiondiv>\n<p>Plasma-phenobarbital concentration for optimum response is 15&#8211;40&#8239;mg/litre (60&#8211;180 micromol/litre); however, monitoring the plasma-drug concentration is less useful than with other drugs because tolerance occurs.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47251\" outputclass=\"treatmentCessation\" rev=\"1.14\" parent=\"/drugs/phenobarbital\">\n<title>Treatment cessation</title>\n<body>\n<section>\n<sectiondiv>\n<p>Avoid abrupt withdrawal (dependence with prolonged use).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47425\" outputclass=\"directionsForAdministration\" rev=\"1.15\" parent=\"/drugs/phenobarbital\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Solution for injection must be diluted before intravenous administration.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>intravenous injection</i>, dilute to a concentration of 20&#8239;mg/mL with Water for Injections; give over 20 minutes (no faster than 1&#8239;mg/kg/minute).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>For administration by <i>mouth</i>, tablets may be crushed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57701\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.16\" parent=\"/drugs/phenobarbital\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Switching between formulations</p>\n<p>Different formulations of oral preparations may vary in bioavailability. Patients should be maintained on a specific manufacturer's product.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Some hospitals supply <b>alcohol-free</b> formulations of varying phenobarbital strengths.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47308\" outputclass=\"patientAndCarerAdvice\" rev=\"1.19\" parent=\"/drugs/phenobarbital\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Phenobarbital for preventing seizures</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/phenobarbital-for-preventing-seizures\">www.medicinesforchildren.org.uk/phenobarbital-for-preventing-seizures</xref>\n</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP2950-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/phenobarbital\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, oral suspension, tablet, capsule</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76286\" title=\"Tablet\" namespace=\"/drugs/phenobarbital/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76306\" title=\"Oral solution\" namespace=\"/drugs/phenobarbital/oral-solution\">Oral solution</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107735\" namespace=\"/guidance/prescribing-in-palliative-care\" title=\"Prescribing in palliative care\" count=\"1\" rel=\"backlink\">Prescribing in palliative care</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97236\" namespace=\"/guidance/emergency-supply-of-medicines\" title=\"Emergency supply of medicines\" count=\"3\" rel=\"backlink\">Emergency supply of medicines</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP98616\" namespace=\"/guidance/prescribing-in-breast-feeding\" title=\"Prescribing in breast-feeding\" count=\"1\" rel=\"backlink\">Prescribing in breast-feeding</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78143\" namespace=\"/treatment-summaries/contraceptives-interactions\" title=\"Contraceptives, interactions\" count=\"1\" rel=\"backlink\">Contraceptives, interactions</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78558\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\" title=\"Emergency treatment of poisoning\" count=\"1\" rel=\"backlink\">Emergency treatment of poisoning</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_437\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/phenobarbital\" title=\"Phenobarbital\" count=\"1\" rel=\"link\">Phenobarbital</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78230\" namespace=\"/treatment-summaries/epilepsy\" title=\"Epilepsy\" count=\"1\" rel=\"link\">Epilepsy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76286\" namespace=\"/drugs/phenobarbital/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76306\" namespace=\"/drugs/phenobarbital/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n</links>\n</topic>",
    "id": "PHP2950",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/phenobarbital",
    "basename": "phenobarbital",
    "title": "PHENOBARBITAL",
    "interactants": [
        {
            "id": "bnf_int_437",
            "label": "Phenobarbital"
        }
    ],
    "vtmid": "51073002",
    "drugClassification": [
        "Barbiturates"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Phenobarbitone"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "All forms of epilepsy except typical absence seizures",
                        "html": "All forms of epilepsy except typical absence seizures"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 1&#8211;1.5 mg/kg twice daily, then increased in steps of 2 mg/kg daily as required; maintenance 2.5&#8211;4 mg/kg 1&#8211;2 times a day.",
                        "html": "<p>Initially 1&#8211;1.5&#8239;mg/kg twice daily, then increased in steps of 2&#8239;mg/kg daily as required; maintenance 2.5&#8211;4&#8239;mg/kg 1&#8211;2 times a day.</p>",
                        "ageGroup": "1 month&#8211;11 years"
                    },
                    {
                        "textContent": "60&#8211;180 mg once daily, dose to be taken at night.",
                        "html": "<p>60&#8211;180&#8239;mg once daily, dose to be taken at night.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "60&#8211;180 mg once daily, dose to be taken at night.",
                        "html": "<p>60&#8211;180&#8239;mg once daily, dose to be taken at night.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Status epilepticus",
                        "html": "Status epilepticus"
                    }
                ],
                "specificity": {
                    "routes": [
                        "slow intravenous injection"
                    ],
                    "textContent": "By slow intravenous injection",
                    "html": "By slow intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "10 mg/kg (max. per dose 1 g), dose to be administered at a rate not more than 100 mg/minute, injection to be diluted 1 in 10 with water for injections.",
                        "html": "<p>10&#8239;mg/kg (max. per dose 1&#8239;g), dose to be administered at a rate not more than 100&#8239;mg/minute, injection to be diluted 1 in 10 with water for injections.</p>"
                    }
                ],
                "neonate": [
                    {
                        "textContent": "Initially 20 mg/kg, dose to be administered at a rate no faster than 1 mg/kg/minute, then 2.5&#8211;5 mg/kg 1&#8211;2 times a day.",
                        "html": "<p>Initially 20&#8239;mg/kg, dose to be administered at a rate no faster than 1&#8239;mg/kg/minute, then 2.5&#8211;5&#8239;mg/kg 1&#8211;2 times a day.</p>"
                    }
                ],
                "child": [
                    {
                        "textContent": "Initially 20 mg/kg, dose to be administered at a rate no faster than 1 mg/kg/minute, then 2.5&#8211;5 mg/kg 1&#8211;2 times a day.",
                        "html": "<p>Initially 20&#8239;mg/kg, dose to be administered at a rate no faster than 1&#8239;mg/kg/minute, then 2.5&#8211;5&#8239;mg/kg 1&#8211;2 times a day.</p>",
                        "ageGroup": "1 month&#8211;11 years"
                    },
                    {
                        "textContent": "Initially 20 mg/kg (max. per dose 1 g), dose to be administered at a rate no faster than 1 mg/kg/minute, then 300 mg twice daily.",
                        "html": "<p>Initially 20&#8239;mg/kg (max. per dose 1&#8239;g), dose to be administered at a rate no faster than 1&#8239;mg/kg/minute, then 300&#8239;mg twice daily.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "For therapeutic purposes phenobarbital and phenobarbital sodium may be considered equivalent in effect.",
                "html": "<p>For therapeutic purposes phenobarbital and phenobarbital sodium may be considered equivalent in effect.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Avoid in Acute porphyrias",
                "html": "Avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "cautions",
                "textContent": "children",
                "html": "children"
            },
            {
                "type": "cautions",
                "textContent": "debilitated",
                "html": "debilitated"
            },
            {
                "type": "cautions",
                "textContent": "elderly in adults",
                "html": "elderly in adults",
                "specificity": {
                    "patientType": "adults"
                }
            },
            {
                "type": "cautions",
                "textContent": "history of alcohol abuse",
                "html": "history of alcohol abuse"
            },
            {
                "type": "cautions",
                "textContent": "history of drug abuse",
                "html": "history of drug abuse"
            },
            {
                "type": "cautions",
                "textContent": "respiratory depression (avoid if severe)",
                "html": "respiratory depression (avoid if severe)"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "Consider vitamin D supplementation in patients who are immobilised for long periods or who have inadequate sun exposure or dietary intake of calcium.",
                "html": "<p>Consider vitamin D supplementation in patients who are immobilised for long periods or who have inadequate sun exposure or dietary intake of calcium.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (phenobarbital).",
                "html": "<p>Appendix 1 (phenobarbital).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Agranulocytosis",
                        "html": "Agranulocytosis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "allergic skin reactions",
                        "html": "allergic skin reactions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "ataxia",
                        "html": "ataxia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "behavioural disturbances",
                        "html": "behavioural disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "cholestasis",
                        "html": "cholestasis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hallucinations",
                        "html": "hallucinations",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hepatitis",
                        "html": "hepatitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hyperactivity particularly in the elderly and in children",
                        "html": "hyperactivity particularly in the elderly and in children",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "impaired cognition",
                        "html": "impaired cognition",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "impaired memory",
                        "html": "impaired memory",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "irritability",
                        "html": "irritability",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "lethargy",
                        "html": "lethargy",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "megaloblastic anaemia (may be treated with folic acid)",
                        "html": "megaloblastic anaemia (may be treated with folic acid)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nystagmus",
                        "html": "nystagmus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "osteomalacia",
                        "html": "osteomalacia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "paradoxical excitement in adults",
                        "html": "paradoxical excitement in adults",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common",
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "respiratory depression",
                        "html": "respiratory depression",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Antiepileptic Hypersensitivity Syndrome",
                        "html": "Antiepileptic Hypersensitivity Syndrome",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "suicidal ideation",
                        "html": "suicidal ideation",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Hyperkinesia in children",
                        "html": "Hyperkinesia in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known",
                            "patientType": "children"
                        }
                    }
                ]
            }
        },
        "overdosageInformation": [
            {
                "type": "overdosageInformation",
                "title": "Emergency treatment of poisoning: active elimination techniques",
                "textContent": "Repeated doses of activated charcoal by mouth enhance the elimination of some drugs after they have been absorbed; repeated doses are given after overdosage with phenobarbital.\n\nThe usual dose of activated charcoal in adults and children over 12 years of age is 50 g initially then 50 g every 4 hours. Vomiting should be treated (e.g. with an antiemetic drug) since it may reduce the efficacy of charcoal treatment. In cases of intolerance, the dose may be reduced and the frequency increased (e.g. 25 g every 2 hours or 12.5 g every hour) but this may compromise efficacy.\n\nIn children under 12 years of age, activated charcoal is given in a dose of 1 g/kg (max. 50 g) every 4 hours; the dose may be reduced and the frequency increased if not tolerated.\n\nOther techniques intended to enhance the elimination of poisons after absorption are only practicable in hospital and are only suitable for a small number of severely poisoned patients. Moreover, they only apply to a limited number of poisons, for example, haemodialysis for phenobarbital.",
                "html": "<p>Repeated doses of activated charcoal by mouth <i>enhance</i> the elimination of some drugs after they have been absorbed; repeated doses are given after overdosage with phenobarbital.</p><p>The usual dose of activated charcoal in adults and children over 12 years of age is 50&#8239;g initially then 50&#8239;g every 4 hours. Vomiting should be treated (e.g. with an antiemetic drug) since it may reduce the efficacy of charcoal treatment. In cases of intolerance, the dose may be reduced and the frequency increased (e.g. 25&#8239;g every 2 hours or 12.5&#8239;g every hour) but this may compromise efficacy.</p><p>In children under 12 years of age, activated charcoal is given in a dose of 1&#8239;g/kg (max. 50&#8239;g) every 4 hours; the dose may be reduced and the frequency increased if not tolerated.</p><p>Other techniques intended to enhance the elimination of poisons after absorption are only practicable in hospital and are only suitable for a small number of severely poisoned patients. Moreover, they only apply to a limited number of poisons, for example, haemodialysis for phenobarbital.</p>"
            }
        ]
    },
    "allergyAndCrossSensitivity": {
        "crossSensitivity": [
            {
                "type": "crossSensitivity",
                "references": [
                    {
                        "id": "PHP78230",
                        "label": "Epilepsy"
                    }
                ],
                "textContent": "Antiepileptic hypersensitivity syndrome associated with phenobarbital. See under Epilepsy for more information.",
                "html": "<p>Antiepileptic hypersensitivity syndrome associated with phenobarbital. See under <xref format=\"dita\" href=\"#PHP78230\" type=\"bookmark\" namespace=\"/treatment-summaries/epilepsy\">Epilepsy</xref> for more information.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid if possible; drowsiness may occur.",
                "html": "<p>Avoid if possible; drowsiness may occur.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "May precipitate coma.\n\nAvoid in severe impairment.",
                "html": "<p>May precipitate coma.</p><p>Avoid in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "therapeuticDrugMonitoring": [
            {
                "type": "therapeuticDrugMonitoring",
                "textContent": "Plasma-phenobarbital concentration for optimum response is 15&#8211;40 mg/litre (60&#8211;180 micromol/litre); however, monitoring the plasma-drug concentration is less useful than with other drugs because tolerance occurs.",
                "html": "<p>Plasma-phenobarbital concentration for optimum response is 15&#8211;40&#8239;mg/litre (60&#8211;180 micromol/litre); however, monitoring the plasma-drug concentration is less useful than with other drugs because tolerance occurs.</p>"
            }
        ]
    },
    "treatmentCessation": {
        "treatmentCessation": [
            {
                "type": "treatmentCessation",
                "textContent": "Avoid abrupt withdrawal (dependence with prolonged use).",
                "html": "<p>Avoid abrupt withdrawal (dependence with prolonged use).</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Solution for injection must be diluted before intravenous administration.",
                "html": "<p>Solution for injection must be diluted before intravenous administration.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous injection, dilute to a concentration of 20 mg/mL with Water for Injections; give over 20 minutes (no faster than 1 mg/kg/minute).",
                "html": "<p>For <i>intravenous injection</i>, dilute to a concentration of 20&#8239;mg/mL with Water for Injections; give over 20 minutes (no faster than 1&#8239;mg/kg/minute).</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "For administration by mouth, tablets may be crushed.",
                "html": "<p>For administration by <i>mouth</i>, tablets may be crushed.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "title": "Switching between formulations",
                "textContent": "Different formulations of oral preparations may vary in bioavailability. Patients should be maintained on a specific manufacturer's product.",
                "html": "<p>Different formulations of oral preparations may vary in bioavailability. Patients should be maintained on a specific manufacturer's product.</p>"
            },
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Some hospitals supply alcohol-free formulations of varying phenobarbital strengths.",
                "html": "<p>Some hospitals supply <b>alcohol-free</b> formulations of varying phenobarbital strengths.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/phenobarbital-for-preventing-seizures",
                        "label": "www.medicinesforchildren.org.uk/phenobarbital-for-preventing-seizures"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Phenobarbital for preventing seizures",
                "textContent": "www.medicinesforchildren.org.uk/phenobarbital-for-preventing-seizures",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/phenobarbital-for-preventing-seizures\">www.medicinesforchildren.org.uk/phenobarbital-for-preventing-seizures</xref>\n</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "oral suspension",
                "tablet",
                "capsule"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76286",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76306",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP107735",
                "label": "Prescribing in palliative care",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP97236",
                "label": "Emergency supply of medicines",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP98616",
                "label": "Prescribing in breast-feeding",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78143",
                "label": "Contraceptives, interactions",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78558",
                "label": "Emergency treatment of poisoning",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_437",
                "label": "Phenobarbital",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78230",
                "label": "Epilepsy",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76286",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76306",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    }
}